Factors controlling the turnover of T memory cells

Immunological Reviews
J SprentS Sun

Abstract

Most of the T cells participating in the primary immune response are rapidly eliminated, but small numbers of these cells survive and differentiate into long-lived memory cells. Information on the life history of memory cells can be obtained by studying the component of memory-phenotype T cells found in normal animals; these cells are presumed to represent memory cells specific for various environmental antigens. For CD8+ cells, in vivo exposure to viruses and certain other infectious agents causes a large proportion of memory-phenotype (CD44hi) cells to enter the cell cycle. In this situation, stimulation of CD44hi CD8+ cells does not seem to require T-cell receptor ligation and appears to reflect release of various cytokines, especially type I interferon. The capacity of infectious agents to induce non-antigen-specific stimulation of T cells may play a role in boosting the survival of memory cells and perhaps also in providing an adjuvant function during the primary response.

References

Aug 1, 1992·Immunology Today·S J Korsmeyer
Nov 1, 1991·The Journal of Experimental Medicine·D Gray, P Matzinger
Nov 8, 1990·Nature·E B Bell, S M Sparshott
Jun 1, 1990·Immunology Today·P C Beverley
Nov 3, 1988·Nature·D Gray, H Skarvall
Jul 1, 1986·European Journal of Immunology·F J Dumont, L Z Coker
Jan 1, 1984·Springer Seminars in Immunopathology·H Kirchner
Jan 1, 1980·Advances in Immunology·M J BuchmeierM B Oldstone
Apr 11, 1980·Nucleic Acids Research·A P Bird, M H Taggart
Jun 23, 1994·Nature·L L LauR Ahmed
Apr 7, 1995·Science·M G McHeyzer-Williams, M M Davis
Apr 1, 1995·Current Opinion in Immunology·J Sprent, S R Webb
Jun 1, 1995·Immunology Today·R Scollay, D I Godfrey
Nov 1, 1993·The Journal of Experimental Medicine·C G Romball, W O Weigle
Apr 6, 1995·Nature·A M KriegD M Klinman
Jan 1, 1995·Advances in Virus Research·E S Razvi, R M Welsh
Apr 1, 1994·The Journal of Experimental Medicine·D F Tough, J Sprent
Jan 1, 1994·The Journal of Experimental Medicine·A Müllbacher
Jan 28, 1994·Cell·J Sprent
Jun 1, 1993·Current Opinion in Immunology·J Sprent
Apr 1, 1993·The Journal of Experimental Medicine·H von Boehmer, K Hafen
Jan 1, 1993·Advances in Immunology·C R Mackay
May 1, 1996·The Journal of Experimental Medicine·F Di Rosa, P Matzinger
Apr 1, 1996·The Journal of Experimental Medicine·C ZimmermanH Pircher
Jan 1, 1996·Annual Review of Immunology·R M ZinkernagelH Hengartner
Oct 1, 1996·The Journal of Experimental Medicine·M CorrH Tighe
Dec 1, 1996·The Journal of Experimental Medicine·M PihlgrenJ Marvel

❮ Previous
Next ❯

Citations

Jun 1, 2001·European Journal of Immunology·E B BellS M Sparshott
Jun 1, 2001·Journal of Immunological Methods·D W KowalczykH C Ertl
Dec 29, 1998·Immunology Today·C Tanchot, B Rocha
Sep 29, 1999·Immunology Today·M K Hellerstein
May 14, 1999·Current Opinion in Immunology·A A Freitas, B Rocha
Feb 19, 2002·British Journal of Haematology·Anne Bourguin-PlonquetJean-Pierre Farcet
Jul 18, 2002·Scandinavian Journal of Immunology·V L D BonatoC L Silva
Aug 9, 2002·AIDS Research and Human Retroviruses·Barbara L ShacklettDouglas F Nixon
May 4, 2000·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·C TanchotB Rocha
May 4, 2000·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·P C Beverley, M K Maini
Feb 26, 1998·Immunological Reviews·N R Klinman, G H Kline
Jun 3, 2000·Annual Review of Immunology·A A Freitas, B Rocha
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·K J FlynnP C Doherty
Jan 5, 2001·Expert Opinion on Investigational Drugs· van Noort JM
Dec 16, 2011·Immunological Reviews·Gérard Eberl
Feb 29, 2000·Cell·J D BuiS M Hedrick
Sep 7, 2001·Annual Review of Microbiology·S RedpathP Ghazal
Aug 4, 2004·The Lancet Infectious Diseases·S K ObaroK Luzuriaga
Apr 13, 2000·Pediatric Clinics of North America·M E Pichichero
Mar 23, 2001·Nature Immunology·H Veiga-FernandesB Rocha
Dec 3, 2003·Nature Immunology·Henrique Veiga-Fernandes, Benedita Rocha
May 3, 2002·Clinical and Diagnostic Laboratory Immunology·K S KrabbeB K Pedersen
May 9, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·D F ToughJ Sprent
Feb 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Denis FranchimontJohn J O'Shea
Jul 5, 2002·The Journal of Nutrition·Kathryn PinnaJanet C King
Jul 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M C NawijnR W Hendriks
Sep 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·María-Eugenia Miranda-CarúsEmilio Martín-Mola
Dec 12, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·J E UzonnaP Bretscher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.